138 related articles for article (PubMed ID: 19414330)
21. Unraveling the Ligand-Binding Sites of CYP3A4 by Molecular Dynamics Simulations with Solvent Probes.
Feng Y; Gong C; Zhu J; Liu G; Tang Y; Li W
J Chem Inf Model; 2024 Apr; 64(8):3451-3464. PubMed ID: 38593186
[TBL] [Abstract][Full Text] [Related]
22. A Covalently Attached Progesterone Molecule Outcompetes the Binding of Free Progesterone at an Allosteric Site of Cytochrome P450 3A4.
Ducharme J; Polic V; Auclair K
Bioconjug Chem; 2019 Jun; 30(6):1629-1635. PubMed ID: 31083930
[TBL] [Abstract][Full Text] [Related]
23. Nanodisc-embedded cytochrome P450 P3A4 binds diverse ligands by distributing conformational dynamics to its flexible elements.
Paço L; Hackett JC; Atkins WM
J Inorg Biochem; 2023 Jul; 244():112211. PubMed ID: 37080138
[TBL] [Abstract][Full Text] [Related]
24. Steroid bioconjugation to a CYP3A4 allosteric site and its effect on substrate binding and coupling efficiency.
Polic V; Sevrioukova IF; Auclair K
Arch Biochem Biophys; 2018 Sep; 653():90-96. PubMed ID: 29958895
[TBL] [Abstract][Full Text] [Related]
25. Flexibility of human cytochrome P450 enzymes: molecular dynamics and spectroscopy reveal important function-related variations.
Hendrychová T; Anzenbacherová E; Hudeček J; Skopalík J; Lange R; Hildebrandt P; Otyepka M; Anzenbacher P
Biochim Biophys Acta; 2011 Jan; 1814(1):58-68. PubMed ID: 20656072
[TBL] [Abstract][Full Text] [Related]
26. Cytochrome P450 3A4 inhibition by ketoconazole: tackling the problem of ligand cooperativity using molecular dynamics simulations and free-energy calculations.
Bren U; Oostenbrink C
J Chem Inf Model; 2012 Jun; 52(6):1573-82. PubMed ID: 22587011
[TBL] [Abstract][Full Text] [Related]
27. Pi-pi Stacking Mediated Cooperative Mechanism for Human Cytochrome P450 3A4.
Fa B; Cong S; Wang J
Molecules; 2015 Apr; 20(5):7558-73. PubMed ID: 25919277
[TBL] [Abstract][Full Text] [Related]
28. The use of isomeric testosterone dimers to explore allosteric effects in substrate binding to cytochrome P450 CYP3A4.
Denisov IG; Mak PJ; Grinkova YV; Bastien D; Bérubé G; Sligar SG; Kincaid JR
J Inorg Biochem; 2016 May; 158():77-85. PubMed ID: 26774838
[TBL] [Abstract][Full Text] [Related]
29. CYP3A4-Mediated carbamazepine (CBZ) metabolism: formation of a covalent CBZ-CYP3A4 adduct and alteration of the enzyme kinetic profile.
Kang P; Liao M; Wester MR; Leeder JS; Pearce RE; Correia MA
Drug Metab Dispos; 2008 Mar; 36(3):490-9. PubMed ID: 18096676
[TBL] [Abstract][Full Text] [Related]
30. Structural basis for regiospecific midazolam oxidation by human cytochrome P450 3A4.
Sevrioukova IF; Poulos TL
Proc Natl Acad Sci U S A; 2017 Jan; 114(3):486-491. PubMed ID: 28031486
[TBL] [Abstract][Full Text] [Related]
31. Structures of prostacyclin synthase and its complexes with substrate analog and inhibitor reveal a ligand-specific heme conformation change.
Li YC; Chiang CW; Yeh HC; Hsu PY; Whitby FG; Wang LH; Chan NL
J Biol Chem; 2008 Feb; 283(5):2917-26. PubMed ID: 18032380
[TBL] [Abstract][Full Text] [Related]
32. Understanding the mechanism of cytochrome P450 3A4: recent advances and remaining problems.
Sevrioukova IF; Poulos TL
Dalton Trans; 2013 Mar; 42(9):3116-26. PubMed ID: 23018626
[TBL] [Abstract][Full Text] [Related]
33. High-Level Production and Properties of the Cysteine-Depleted Cytochrome P450 3A4.
Sevrioukova IF
Biochemistry; 2017 Jun; 56(24):3058-3067. PubMed ID: 28590129
[TBL] [Abstract][Full Text] [Related]
34. Visible spectra of type II cytochrome P450-drug complexes: evidence that "incomplete" heme coordination is common.
Locuson CW; Hutzler JM; Tracy TS
Drug Metab Dispos; 2007 Apr; 35(4):614-22. PubMed ID: 17251307
[TBL] [Abstract][Full Text] [Related]
35. Surface plasmon resonance analysis of antifungal azoles binding to CYP3A4 with kinetic resolution of multiple binding orientations.
Pearson JT; Hill JJ; Swank J; Isoherranen N; Kunze KL; Atkins WM
Biochemistry; 2006 May; 45(20):6341-53. PubMed ID: 16700545
[TBL] [Abstract][Full Text] [Related]
36. Prediction of sites of metabolism in a substrate molecule, instanced by carbamazepine oxidation by CYP3A4.
Yuki H; Honma T; Hata M; Hoshino T
Bioorg Med Chem; 2012 Jan; 20(2):775-83. PubMed ID: 22197672
[TBL] [Abstract][Full Text] [Related]
37. Flexibility of human cytochromes P450: molecular dynamics reveals differences between CYPs 3A4, 2C9, and 2A6, which correlate with their substrate preferences.
Skopalík J; Anzenbacher P; Otyepka M
J Phys Chem B; 2008 Jul; 112(27):8165-73. PubMed ID: 18598011
[TBL] [Abstract][Full Text] [Related]
38. Ketoconazole-induced conformational changes in the active site of cytochrome P450eryF.
Cupp-Vickery JR; Garcia C; Hofacre A; McGee-Estrada K
J Mol Biol; 2001 Aug; 311(1):101-10. PubMed ID: 11469860
[TBL] [Abstract][Full Text] [Related]
39. Concurrent cooperativity and substrate inhibition in the epoxidation of carbamazepine by cytochrome P450 3A4 active site mutants inspired by molecular dynamics simulations.
Müller CS; Knehans T; Davydov DR; Bounds PL; von Mandach U; Halpert JR; Caflisch A; Koppenol WH
Biochemistry; 2015 Jan; 54(3):711-21. PubMed ID: 25545162
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of drug-drug interactions mediated by human cytochrome P450 CYP3A4 monomer.
Denisov IG; Grinkova YV; Baylon JL; Tajkhorshid E; Sligar SG
Biochemistry; 2015 Apr; 54(13):2227-39. PubMed ID: 25777547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
